IUCLID
CVEs (3)
| CVE | Vendor / Product | Sev | Risk | CVSS | EPSS | KEV | Published | Description |
|---|---|---|---|---|---|---|---|---|
| CVE-2023-26089 | Cri | 0.64 | 9.8 | 0.01 | May 2, 2023 | European Chemicals Agency IUCLID 6.x before 6.27.6 allows authentication bypass because a weak hard-coded secret is used for JWT signing. The affected versions are 5.15.0 through 6.27.5. | ||
| CVE-2023-26546 | Hig | 0.57 | 8.8 | 0.01 | May 2, 2023 | European Chemicals Agency IUCLID before 6.27.6 allows remote authenticated users to execute arbitrary code via Server Side Template Injection (SSTI) with a crafted template file. The attacker must have template manager permission. | ||
| CVE-2024-0770 | Med | 0.29 | 4.4 | 0.00 | Jan 21, 2024 | A vulnerability, which was classified as critical, was found in European Chemicals Agency IUCLID 7.10.3 on Windows. Affected is an unknown function of the file iuclid6.exe of the component Desktop Installer. The manipulation leads to incorrect default permissions. The attack… |
- risk 0.64cvss 9.8epss 0.01
European Chemicals Agency IUCLID 6.x before 6.27.6 allows authentication bypass because a weak hard-coded secret is used for JWT signing. The affected versions are 5.15.0 through 6.27.5.
- risk 0.57cvss 8.8epss 0.01
European Chemicals Agency IUCLID before 6.27.6 allows remote authenticated users to execute arbitrary code via Server Side Template Injection (SSTI) with a crafted template file. The attacker must have template manager permission.
- risk 0.29cvss 4.4epss 0.00
A vulnerability, which was classified as critical, was found in European Chemicals Agency IUCLID 7.10.3 on Windows. Affected is an unknown function of the file iuclid6.exe of the component Desktop Installer. The manipulation leads to incorrect default permissions. The attack…